All Updates

All Updates

icon
Filter
Funding
EvolutionaryScale raises USD 142 million in seed funding to develop protein-generating AI models
AI Drug Discovery
Jun 25, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Jun 25, 2024

EvolutionaryScale raises USD 142 million in seed funding to develop protein-generating AI models

Funding

  • GenAI-powered protein generator EvolutionaryScale has raised USD 142 million in a seed round led by Nat Friedman, Daniel Gross, and Lux Capital, with participation from Amazon and NVenture, NVIDIA's venture arm.

  • The funds will be directed toward scaling up its model training to include data beyond proteins and to construct a uniquely versatile AI model relevant to biotech applications. Its ESM3 model is claimed to be trained on 2.78 billion proteins, allowing it to generate novel proteins intended for use in scientific discovery and material science. 

  • EvolutionaryScale is an AI biotechnology company that leverages advanced AI models to predict protein structures to support drug development, environmental remediation, and other biotech applications. Founded in 2023, the company’s technology builds on transformers-based models specialized in biological data, particularly protein molecules.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.